These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Effect of poldine (Nacton) on gastric secretion during treatment of peptic ulcer]. Kopriva V; Svác J; Bilkovic R Cesk Gastroenterol Vyz; 1973 Jun; 27(4):242-5. PubMed ID: 4740807 [No Abstract] [Full Text] [Related]
45. The pharmacology of peptic ulcer disease. Ippoliti A; Peterson W Clin Gastroenterol; 1979 Jan; 8(1):53-67. PubMed ID: 369747 [No Abstract] [Full Text] [Related]
46. [STUDY OF THE CLINICAL EFFECTS AND ANTI-GASTRIC SECRETORY ACTION OF THE BENZYL ESTER OF 1,1-DIETHYL-3-HYDROXYPYRROLIDINIUM BROMIDE]. TRAISSAC FJ; BERAUD C; MARAMBAT G Gaz Med Fr; 1964 Apr; 71():1614-7. PubMed ID: 14145724 [No Abstract] [Full Text] [Related]
47. Some pitfalls in antisecretory drug trials. Subject selection, collection period, and daytime variation. Moore JG; Englert E Am J Dig Dis; 1967 Oct; 12(10):973-82. PubMed ID: 4859804 [No Abstract] [Full Text] [Related]
48. [The effect of ACTH on the secretion of gastromucoproteins and other components of gastric juice]. Khitarov MZ Vrach Delo; 1968 Nov; 11():129-30. PubMed ID: 4314873 [No Abstract] [Full Text] [Related]
49. THE EFFECT OF GLYCOPYRROLATE ON NOCTURNAL GASTRIC SECRETION IN PEPTIC ULCER PATIENTS. BARMAN ML; LARSON RK Am J Med Sci; 1963 Sep; 246():325-8. PubMed ID: 14063751 [No Abstract] [Full Text] [Related]
50. A comparison of oxyphencyclimine hydrochloride and propantheline bromide in patients with duodenal ulcer. Alea JA; Aquilina JT Am J Dig Dis; 1967 Nov; 12(11):1122-30. PubMed ID: 4383347 [No Abstract] [Full Text] [Related]
51. Pentapiperide methylsulfate (Quilene). Anticholinergic with antisecretory and antimotility activity on the upper gastrointestinal tract for adjunctive therapy in the management of peptic ulcer. Clin Pharmacol Ther; 1969; 10(6):904-6. PubMed ID: 4900203 [No Abstract] [Full Text] [Related]
52. Gastric secretion and peptic ulcer following portacaval shunt in man. Orloff MJ; Chandler JG; Alderman SJ; Keiter JE; Rosen H Ann Surg; 1969 Oct; 170(4):515-27. PubMed ID: 5344030 [No Abstract] [Full Text] [Related]
53. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans]. Sampietro R Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329 [No Abstract] [Full Text] [Related]
56. New therapeutic agents for peptic ulcer. Augur NA J Maine Med Assoc; 1971 Oct; 62(10):245-6 passim. PubMed ID: 4937792 [No Abstract] [Full Text] [Related]
57. [Clinical and experimental studies on the effect of neuroplegic drugs on gastric secretion and peptic ulcers]. Moczurad K Folia Med Cracov; 1974; 16(4):413-26. PubMed ID: 4475657 [No Abstract] [Full Text] [Related]
58. Effect of lapachol, a naphthaquinone isolated from Tectona grandis, on experimental peptic ulcer and gastric secretion. Goel RK; Pathak NK; Biswas M; Pandey VB; Sanyal AK J Pharm Pharmacol; 1987 Feb; 39(2):138-40. PubMed ID: 2882001 [TBL] [Abstract][Full Text] [Related]
59. [Study on the duration of action of a new substance, parapenzolate bromide, by an original method]. Boisson J Therapeutique; 1969 Nov; 45(9):894-6. PubMed ID: 5365418 [No Abstract] [Full Text] [Related]